In late July 2025, a claim (archived) circulated online that U.S. Health and Human Services Secretary Robert F. Kennedy Jr.

Prasad stepped down as the Director of the Center for Biologics Evaluation and Research (CBER) on Tuesday, nearly three months into the job.